NPC

American Barbell Unveils Cutting-Edge Fitness Gear at IHRSA for Athletes Who Demand Peak Performance

Retrieved on: 
Tuesday, February 13, 2024

Las Vegas, NV, Feb. 13, 2024 (GLOBE NEWSWIRE) -- At the upcoming IHRSA in Los Angeles, American Barbell is set to showcase its latest collection of high-end fitness equipment crafted for athletes who prioritize performance.

Key Points: 
  • Las Vegas, NV, Feb. 13, 2024 (GLOBE NEWSWIRE) -- At the upcoming IHRSA in Los Angeles, American Barbell is set to showcase its latest collection of high-end fitness equipment crafted for athletes who prioritize performance.
  • American Barbell stands out by designing and manufacturing its own line, continually pushing the boundaries of innovation to deliver equipment that meets the rigorous demands of top athletes.
  • "Our in-house design and manufacturing allow us to create sleek, cutting-edge products that enhance performance," said Doug Katona, CEO of American Barbell.
  • With a legacy dating back to 1978, American Barbell has been a game-changer in the fitness equipment industry.

U.S. Polo Assn. Celebrates the United States Winter Polo Season as Official Sponsor of the USPA National Polo Center (NPC)

Retrieved on: 
Thursday, February 1, 2024

West Palm Beach, FL, Feb 1, 2024 - (ACN Newswire) - U.S. Polo Assn., the official brand of the United States Polo Association (USPA), celebrates this season as the official sponsor of the new USPA National Polo Center (NPC), with exclusive naming rights to Field One as the U.S. Polo Assn.

Key Points: 
  • West Palm Beach, FL, Feb 1, 2024 - (ACN Newswire) - U.S. Polo Assn., the official brand of the United States Polo Association (USPA), celebrates this season as the official sponsor of the new USPA National Polo Center (NPC), with exclusive naming rights to Field One as the U.S. Polo Assn.
  • The USPA National Polo Center and U.S. Polo Assn.
  • Stadium Field, branded golf carts for polo player award ceremonies, and the grand opening of the U.S. Polo Assn.
  • The USPA National Polo Center (NPC), the epicenter of winter polo, proudly hosts illustrious global polo events along with some of the most prestigious North American high-goal tournaments.

Junshi Biosciences Announces Toripalimab’s NDA Accepted by the Singapore Health Sciences Authority

Retrieved on: 
Friday, February 2, 2024

This NDA was submitted through Project Orbis, an initiative of the US Food and Drug Administration (FDA)’s Oncology Center of Excellence (OCE).

Key Points: 
  • This NDA was submitted through Project Orbis, an initiative of the US Food and Drug Administration (FDA)’s Oncology Center of Excellence (OCE).
  • At present, eight regulatory agencies have joined Project Orbis, including the FDA, the Australia Therapeutic Goods Administration (“TGA”), HSA, Health Canada (HC), the U.K.
  • Previously, two NDAs for toripalimab for the treatment of NPC had been submitted to the TGA through Project Orbis and were successfully accepted.
  • Junshi Biosciences will explore accelerated marketing opportunities in countries and regions where it is applicable.

Azafaros to present data from PRONTO study in patients with GM1 and GM2 gangliosidoses at the 20th annual WORLDSymposium™

Retrieved on: 
Tuesday, January 23, 2024

As well as data from PRONTO, Azafaros will present details of its Phase 2 RAINBOW study, aimed at investigating the safety, tolerability, pharmacokinetics, and pharmacodynamics of nizubaglustat in patients with GM2 gangliosidosis or NPC.

Key Points: 
  • As well as data from PRONTO, Azafaros will present details of its Phase 2 RAINBOW study, aimed at investigating the safety, tolerability, pharmacokinetics, and pharmacodynamics of nizubaglustat in patients with GM2 gangliosidosis or NPC.
  • Title: A natural history study of late-infantile and juvenile GM1 and GM2 gangliosidoses (PRONTO) - patients’ and caregivers’ assessments.
  • Title: A natural history study of late-infantile and juvenile GM1 and GM2 gangliosidoses (PRONTO)- baseline clinical data.
  • Title: A natural history study of late-infantile and juvenile GM1 and GM2 gangliosidoses (PRONTO) - evaluation of different assessments.

Generaitiv Introduces Custom AI Engagement Bots to Empower Digital Communities Everywhere

Retrieved on: 
Thursday, January 18, 2024

Toronto, Canada, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Generaitiv - a decentralized, community-driven AI app store - introduced Custom AI Engagement Bots to provide digital communities with AI image generator bots specifically trained on their content and/or brand imagery.

Key Points: 
  • Toronto, Canada, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Generaitiv - a decentralized, community-driven AI app store - introduced Custom AI Engagement Bots to provide digital communities with AI image generator bots specifically trained on their content and/or brand imagery.
  • Notably, all communities using Generaitiv's Custom AI Bots have a combined Market Cap of over $100 million USD.
  • Generaitiv collaborates with numerous creators within the Generaitiv community to train custom AI models and construct new bots.
  • Lastly, Generaitiv increases the benefits for digital communities using its custom AI bots and $GAI token.

DOCOMO Develops World's First Technology Utilizing Generative AI to Automatically Generate Non-Player Characters in Metaverse

Retrieved on: 
Tuesday, January 16, 2024

TOKYO, Jan 16, 2024 - (JCN Newswire) - NTT DOCOMO, INC. announced today that it has developed a generative AI that automatically generates non-player characters (NPCs), characters not controlled by the player, in the metaverse based solely on text input.

Key Points: 
  • TOKYO, Jan 16, 2024 - (JCN Newswire) - NTT DOCOMO, INC. announced today that it has developed a generative AI that automatically generates non-player characters (NPCs), characters not controlled by the player, in the metaverse based solely on text input.
  • The technology integrates three generative AIs: behavior-logic-generative AI, animation-generative AI,3 and appearance-generative AI.4 The behavior-logic-generative AI and the seamless synchronization of all three types of AI are unique developments by DOCOMO; significant achievements that mark the new technology as cutting-edge.
  • Behavior-logic-generative AI automatically creates a unique behavior tree5 that defines the behavior of NPCs in the metaverse using only text.
  • This technology will be introduced during the "docomo Open House '24" online event beginning on January 17.

FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx

Retrieved on: 
Thursday, January 11, 2024

EMERYVILLE, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today that based upon the U.S. Food and Drug Administration’s (FDA) acceptance of Zevra Therapeutics’ New Drug Application (NDA) for arimoclomol, an orally-delivered, first-in-class therapy for Niemann-Pick disease type C (NPC), XOMA will make a $1 million milestone payment to LadRx.

Key Points: 
  • EMERYVILLE, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today that based upon the U.S. Food and Drug Administration’s (FDA) acceptance of Zevra Therapeutics’ New Drug Application (NDA) for arimoclomol, an orally-delivered, first-in-class therapy for Niemann-Pick disease type C (NPC), XOMA will make a $1 million milestone payment to LadRx.
  • “NPC is an ultra-rare, progressive, neurodegenerative genetic disorder where those living with NPC lose independence due to physical and cognitive limitations, with key neurological impairments presenting in speech, cognition, swallowing, ambulation, and fine motor skills.
  • Arimoclomol has the potential to be the first approved therapy designed to slow the progress of this devastating disease,” stated Brad Sitko, Chief Investment Officer at XOMA.
  • The transaction also included a mid-single-digit to mid-teens royalty rate on commercial sales of aldoxorubicin depending upon the indication, in addition to potential payments of up to $343 million in development and commercial milestones from ImmunityBio.

Wemade Presents MIR4 New Year’s Event ‘Search for the Blue Cintamani Stone’!

Retrieved on: 
Tuesday, January 9, 2024

Wemade’s blockbuster MMORPG MIR4 starts its New Year’s Event “Search for the Blue Cintamani Stone” on January 9.

Key Points: 
  • Wemade’s blockbuster MMORPG MIR4 starts its New Year’s Event “Search for the Blue Cintamani Stone” on January 9.
  • View the full release here: https://www.businesswire.com/news/home/20240109976535/en/
    Wemade is organizing MIR4 New Year's event called "Search for the Blue Cintamani Stone" (Graphic: Wemade)
    “Mir's Blue Cintamani Stone Exchange Shop” opens in MIR4 until Monday, January 22.
  • Players can take the “Blue Cintamani Stone” they received during hunting to the NPC “(2024) Mir” found in big cities of each area to exchange for items such as “Legendary Blue Dragon Statue” and “Yellow Dragon's Surprise Gift Box” which contains various summon tickets.
  • The event “Blue Dragon's 14-Day Check-in” continues through Monday, February 5.

The National Press Club is Now Accepting Entries for the Best in Journalism Awards

Retrieved on: 
Tuesday, January 9, 2024

WASHINGTON, Jan. 9, 2024 /PRNewswire/ -- The National Press Club is now accepting entries for its annual journalism awards, which recognize and honor professional journalists who produced outstanding work in 2023.

Key Points: 
  • WASHINGTON, Jan. 9, 2024 /PRNewswire/ -- The National Press Club is now accepting entries for its annual journalism awards, which recognize and honor professional journalists who produced outstanding work in 2023.
  • The deadline to submit entries is April 30, 2024. Review the full contest details online and find past winners here .
  • Winners will be honored during the 51st Annual National Press Club Journalism Awards Dinner at the National Press Club on Wednesday, Aug. 28, 2024.
  • Founded in 1908, the National Press Club is the world's leading professional organization for journalists.

Meadow Partners with National College Cost Transparency Initiative to Help Students Make Informed Financial Decisions

Retrieved on: 
Tuesday, January 9, 2024

NEW YORK, Jan. 9, 2024 /PRNewswire-PRWeb/ -- Meadow today announced a partnership to provide colleges and universities across the country with access to a net price calculator that reflects all the applicable standards of the College Cost Transparency Initiative, a national movement developed by leaders in higher education representing college presidents, financial aid offices, and admissions and school counselors.

Key Points: 
  • Cost is one the biggest factors for students and families when deciding where to go to college.
  • The initiative is managed by the National Association of Student Financial Aid Administrators (NASFAA).
  • "In a few months, millions of students will begin finalizing decisions about enrolling in college for next fall.
  • We built our NPC to be student friendly and accurate, helping universities to provide students with the financial transparency they deserve."